Investing.com - Imac reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Imac announced earnings per share of $-0.230 on revenue of $3.79M. Analysts polled by Investing.com anticipated EPS of $-0.090 on revenue of $4.3M.
Imac shares are down 66.67% from the beginning of the year , still down 73.76% from its 52 week high of $1.49 set on Friday, January 7, 2022.
Imac shares lost 2.25% in intra-day trade the report.
Imac follows other major Healthcare sector earnings this month
Imac's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar